Creative Planning
AGIO icon

Creative Planning’s Agios Pharmaceuticals AGIO Stock Holding History

Creative Planning’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-100
Closed -$1K – 4551
2016
Q2 		$1K Buy
+100
New +$4.94K ﹤0.01% 4133

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Nomura Asset Management International
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Creative Planning's AGIO Position: Q2 2026 in Review

Creative Planning increased its Agios Pharmaceuticals (AGIO) stake by 62% in Q2 2026, buying an estimated $251K and bringing the position to 21,604 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #2831.

Creative Planning first reported a position in AGIO in Q3 2014 and has held it in 32 quarters since. The position peaked at $1.11M in Q3 2017. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Creative Planning held 21,604 shares of Agios Pharmaceuticals worth $802K as of Q2 2026.
  • Creative Planning bought 8,271 Agios Pharmaceuticals shares in Q2 2026, an estimated $251K.
  • Agios Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2831 holding.
  • Creative Planning first reported a position in Agios Pharmaceuticals in Q3 2014 and has held it in 32 quarters since.
  • Creative Planning's Agios Pharmaceuticals position peaked at $1.11M in Q3 2017.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.